FAPi-46 GA-68 for carcinoma, signet ring cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Jan 2024: Trial started, NCT07629609
  2. 5 Jun 2026: Trial registered, NCT07629609

The trials

NCT07629609: BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

State
Under way
Phase
Phase 2
People
90 planned
Started
16 Jan 2024
Primary completion
Jan 2027
Arms
Cancer patients
Results
None posted
  1. 16 Jan 2024: Trial started
  2. 5 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as [68Ga]Ga-FAPI-46, [68Ga]Ga-FAPI-46 PET/CT.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.